HLUC-Lv201 Firefly Luciferase Lentifect™ SARS-CoV-2 full-length Spike-Pseudotyped Lentiviral Particles (25 µl x 1 vial)

HLUC-Lv201 Firefly Luciferase Lentifect™ SARS-CoV-2 full-length Spike-Pseudotyped Lentiviral Particles (25 µl x 1 vial)

> 1×10^5 TU/ml* or > 1×10^7 RFU/ml* control lentiviral particles ready for transduction, 25 µl

Markers: eGFP/Puro, HLUC

Vector:pReceiver-Lv201

Lentifect™ SARS-CoV-2 Spike-pseudotyped lentivirus products produce a specially-packaged variant of standard lentivirus, whereby the commonly used vesicular stomatitis G (VSV-G) envelope glycoprotein is replaced in a proprietary plasmid mix expressing the Spike (S) protein from SARS-CoV-2, the virus responsible for the COVID-19 pandemic (Ou, X., et al., 2020. Nature Communications doi: 10.1038/s41467-020-15562-9; Hoffman, M., et al., 2020. Cell doi: 10.1016/j.cell.2020.02.052). These particles can be used in vitro, to infect cultured cells expressing ACE2, the receptor for SARS-CoV-2 on multiple tissue types, or in vivo in animal models.

Format: 25 µl x 1 vial